Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.183
+0.002 (1.27%)
At close: Mar 9, 2026, 4:00 PM EDT
0.183
+0.000 (0.05%)
After-hours: Mar 9, 2026, 4:14 PM EDT
Theriva Biologics Employees
Theriva Biologics had 22 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
22
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,190,455
Market Cap
8.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 57 |
| Bolt Biotherapeutics | 40 |
| KALA BIO | 38 |
| NuCana | 22 |
| SeaStar Medical Holding | 19 |
| Iterum Therapeutics | 9 |
| TransCode Therapeutics | 7 |
| Alzamend Neuro | 7 |
TOVX News
- 2 months ago - Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) - GlobeNewsWire
- 4 months ago - Theriva Biologics Provides Response to Unusual Market Action - GlobeNewsWire
- 5 months ago - Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds - GlobeNewsWire
- 5 months ago - Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) - GlobeNewsWire
- 7 months ago - Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results - GlobeNewsWire
- 10 months ago - Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results - GlobeNewsWire
- 10 months ago - Theriva Biologics Announces Closing of $7.5 Million Public Offering - GlobeNewsWire
- 10 months ago - Theriva Biologics Announces Pricing of $7.5 Million Public Offering - GlobeNewsWire